GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (BSP:P1RG34) » Definitions » Shiller PE Ratio

Perrigo Co (BSP:P1RG34) Shiller PE Ratio : (As of May. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Perrigo Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Perrigo Co Shiller PE Ratio Historical Data

The historical data trend for Perrigo Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Shiller PE Ratio Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Perrigo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Perrigo Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perrigo Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Shiller PE Ratio falls into.



Perrigo Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Perrigo Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Perrigo Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.05/120.1096*120.1096
=0.050

Current CPI (Mar. 2024) = 120.1096.

Perrigo Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 2.996 100.773 3.571
201409 1.683 100.474 2.012
201412 1.347 99.576 1.625
201503 -2.105 99.975 -2.529
201506 1.182 100.573 1.412
201509 3.005 100.274 3.599
201512 -1.863 99.676 -2.245
201603 -8.653 99.676 -10.427
201606 -12.769 101.072 -15.174
201609 -36.111 100.274 -43.254
201612 -31.796 99.676 -38.314
201703 1.564 100.374 1.872
201706 -1.615 100.673 -1.927
201709 0.971 100.474 1.161
201712 1.680 100.075 2.016
201803 1.869 100.573 2.232
201806 0.980 101.072 1.165
201809 -2.013 101.371 -2.385
201812 2.291 100.773 2.731
201903 1.805 101.670 2.132
201906 0.270 102.168 0.317
201909 2.760 102.268 3.242
201912 -0.575 102.068 -0.677
202003 3.762 102.367 4.414
202006 2.283 101.769 2.694
202009 -6.102 101.072 -7.251
202012 -6.637 101.072 -7.887
202103 1.578 102.367 1.851
202106 -2.162 103.364 -2.512
202109 -2.323 104.859 -2.661
202112 0.396 106.653 0.446
202203 -0.100 109.245 -0.110
202206 -2.423 112.734 -2.582
202209 -1.940 113.431 -2.054
202212 -0.892 115.425 -0.928
202303 -0.104 117.618 -0.106
202306 0.291 119.611 0.292
202309 0.494 120.708 0.492
202312 -1.176 120.110 -1.176
202403 0.050 120.110 0.050

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Perrigo Co  (BSP:P1RG34) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Perrigo Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Perrigo Co (BSP:P1RG34) Business Description

Traded in Other Exchanges
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Co (BSP:P1RG34) Headlines

No Headlines